A History of Self-Harm in Britain A Genealogy of Cutting and Overdosing / by Millard, Chris

Subjects: Link to Metadata

An Oral History of the Special Olympics in China Volume 2 The Movement /

Table of Contents: “…LZ at the Sunshine Home -- Down Syndrome Boy Loving History Books -- Observation of Wei Yang at the Sunshine Home -- Observation of Xiaodong Yu at the Sunshine Home -- A Telephone Operator at a Sunshine Workshop -- Great Expectations, Now That My Special Olympics Hero Got His Own Daughter -- Observation of Miss F at School.…”
Link to Metadata

A History of Radionuclide Studies in the UK 50th Anniversary of the British Nuclear Medicine Society /

Table of Contents: “…Introduction: The history of Nuclear Medicine in the UK -- The evolution from Radioisotope departments administered by Physicists with an emphasis on in vitro and vivo investigations to Nuclear Medicine Departments encompassing Imaging and therapy -- The history of the British Nuclear Medicine Society -- The development of the society from primarily a medical group to a scientific society which includes all disciplines -- From Houseman to Consultant in Nuclear Medicine -- The evolution of training in Nuclear Medicine, to include the MSc and RCR training -- Technician and Radiographer to Clinical Practitioner -- The Institute of Nuclear Medicine -- Radionuclide studies of the pathology of the brain -- Nuclear Cardiology + The Royal Brompton Department -- Paediatric radioisotope studies + Great Ormond Street Dept -- Renal studies + St Barts Department -- Radiotracer studies of human physiology -- Nuclear Medicine at the Hammersmith Including Malcolm Merrick's work -- Monoclonal Antibody studies plus Nuclear Medicine in Nottingham -- Development of medical cyclotrons and PET in the UK -- Bone radionuclide imaging and quantitation and bone densitometry -- Radionuclide Therapy -- Hospital Radiopharmacy -- Evolution of nuclear medicine physics in the UK -- Development of computers in Nuclear Medicine -- The history of the protection of the patient in human radionuclide studies in the clinic and research -- The future direction of radiopharmaceutical development.…”
Link to Metadata

The New Common How the COVID-19 Pandemic is Transforming Society /

Table of Contents: “…Protecting the Vulnerable in a Post-COVID Society -- Can AI Help to Avert the Environmental Great Filter? -- Values and Principles as Cornerstones of a Renewed Normal -- A New Democratic Norm(al)? …”
Link to Metadata

Public Health in Pharmacy Practice A Casebook by Covvey, Jordan R, Arya, Vibhuti, Mager, Natalie A. DiPietro

Table of Contents: “…A pharmacist’s obligation: advocating for change -- 54. The great undoing: a multigenerational journey from racism to social determinants of health…”
Access online version

Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension

Table of Contents: “…PART I: Basic Science of Pulmonary Development and Pulmonary Arterial Disease -- 1 Perspective for Part I -- 2 The alveolar stem cell niche of the mammalian lung -- 3 Lung development and Notch signalling -- 4 Specialized smooth muscle cell progenitors in pulmonary hypertension -- 5 Diverse Pharmacology of Prostacyclin Mimetics: Implications for Pulmonary Hypertension -- 6 Endothelial-to-mesenchymal transition in pulmonary hypertension -- 7 Extracellular vesicles, MicroRNAs and Pulmonary Hypertension -- 8 Roles of Tbx4 in the lung mesenchyme for airway and vascular development -- 9 A lacZ reporter transgenic mouse line revealing the development of pulmonary artery -- 10 Roles of stem cell antigen-1 in the pulmonary endothelium -- 11 Morphological characterization of pulmonary microvascular disease in bronchopulmonary dysplasia caused by hyperoxia in newborn mice -- 12 Involvement of CXCR4 and stem cells in a rat model of pulmonary arterial hypertension -- 13 Ca2+ signal through inositol trisphosphate receptors for cardiovascular development and pathophysiology of pulmonary arterial hypertension -- PART II: Abnormal pulmonary circulation in the developing lung and heart -- 14 Perspective for Part II -- 15 Pathophysiology of Pulmonary Circulation in Congenital Heart Disease -- 16 Development of Novel Therapies for Pulmonary Hypertension by Clinical Application of Basic Research -- 17 Using Patient-Specific Induced Pluripotent Stem Cells to Understand and Treat Pulmonary Arterial Hypertension -- 18 Modeling pulmonary arterial hypertension using induced pluripotent stem cells -- 19 Dysfunction and restoration of endothelial cell communications in Pulmonary Arterial Hypertension: Therapeutic implications -- 20 Inflammatory Cytokines in the Pathogenesis of Pulmonary Arterial Hypertension -- 21 Genotypes and Phenotypes of Chinese Pediatric Patients with Idiopathic and Heritable Pulmonary Arterial Hypertension- Experiences from A Single Center -- 22 Fundamental Insight into Pulmonary Vascular Disease : Perspectives from Pediatric PAH in Japan -- 23 Risk stratification in paediatric pulmonary arterial hypertension -- 24 The Adaptive Right Ventricle in Eisenmenger Syndrome: Potential Therapeutic Targets for Pulmonary Hypertension -- 25 Impaired right coronary vasodilator function in pulmonary hypertensive rat assessed by in vivo synchrotron microangiography -- 26 Relationship between mutations in ENG and ALK1 gene and the affected organs in hereditary hemorrhagic telangiectasia -- 27 A genetic analysis for patients with pulmonary arterial hypertension -- 28 Evaluation and visualization of right ventricle using three dimensional echocardiography -- 29 Pulmonary hypertension associated with post-operative Tetralogy of Fallot -- 30 Microscopic Lung Airway Abnormality and Pulmonary Vascular Disease Associated with Congenital Systemic to Pulmonary Shunt -- 31 Respiratory syncytial virus infection in infants with heart and lung diseases -- PART III: Ductus arteriosus: bridge over troubled vessels -- 32 Perspective for Part III -- 33 The ductus arteriosus, a vascular outsider, in relation to the pulmonary circulation -- 34 Molecular, genetic, and pharmacological modulation of the ductus arteriosus: KATP channels as novel drug targets -- 35 New mediators in the biology of the ductus arteriosus: Lessons from the chicken embryo -- 36 Constriction of the Ductus Arteriosus with KATP Channel Inhibitors -- 37 New insights on how to treat patent ductus arteriosus -- 38 Antenatal Administration of Betamethasone Contributes to Intimal thickening of the Ductus Arteriosus -- 39 Prostaglandin E-EP4-mediated fibulin-1 up-regulation plays a role in intimal thickening of the ductus arteriosus -- 40 Transcriptional profiles in the chicken ductus arteriosus during hatching -- 41 Inhibition of Cyclooxygenase Contracts Chicken Ductus Arteriosus -- 42 Prostaglandin E2 receptor EP4 inhibition constricts the rat ductus arteriosus -- 43 Dilatation of the Ductus Arteriosus by Diazoxide in Fetal and Neonatal Rats -- 44 The Effect of Long-term Administration of Plostaglandin E1 on Morphological Changes in Ductus Arteriosus -- 45 Significance of SGK1 as a protein kinase transcriptionally regulated by ALK1 signaling in vascular endothelial cells -- 46 Fabrication of Implantable Human Arterial Graft by Periodic Hydrostatic Pressure -- 47 Optimum preparation of Candida albicans cell wall extra (CAWE) for the mouse model of Kawasaki disease -- PART IV: Development and Regeneration of the Cardiovascular System -- 48 Perspective for Part IV -- 49 Advances in the second heart field -- 50 Novel cardiac progenitors for all components of the heart except for the right ventricle -- 51 Regional and TBX5-dependent gene expression in the atria: Implications for pulmonary vein development and atrial fibrillation -- 52 The Endocardium as a Master Regulator of Ventricular Trabeculation -- 53 The Role of Alternative mRNA Splicing in Heart Development -- 54 Progress in the Generation of Multiple Lineage Human-iPSC-derived 3D Engineered Cardiac Tissues for Cardiac Repair -- 55 Quantification of contractility in stem cell derived cardiomyocytes -- 56 A neurotrophic factor receptor GFRA2, a specific surface antigen for cardiac progenitor cells, regulates the process of myocardial compaction -- 57 Cardiac cell specification and differentiation by the defined factors -- 58 A Temporo-Spatial Regulation of Sema3c is Essential for Interaction of Progenitor Cells during Cardiac Outflow Tract Development -- 59 Spatiotemporally restricted developmental alterations in the anterior and secondary heart fields cause distinct conotruncal heart defects -- 60 Significance of transcription factors in the mechanisms of great artery malformations -- 61 The different c-kit expression in human induced pluripotent stem (iPS) cells between with feeder cells and without feeder cells -- 62 Establishment of induced pluripotent stem cells from immortalized B cell lines and their differentiation into cardiomyocytes -- 63 Establishment of an in vitro LQT3 model, using induced pluripotent stem cells from LQT3 patient-derived cardiomyocytes -- 64 Genetic Assessments for clinical courses of Left ventricle noncompaction -- 65 Elucidating the pathogenesis of congenital heart disease in the era of next-generation sequencing.…”
Link to Metadata

Robotic Surgery of Colon and Rectum

Link to Metadata

Urinalysis Atlas A Pictorial Guide to Formed Elements in Urine (Doty and Taylor) by Taylor, Dawn, Doty, Caroline

Access online version

Aging Well Solutions to the Most Pressing Global Challenges of Aging / by Galiana, Jean, Haseltine, William A.

Link to Metadata

P5 eHealth: An Agenda for the Health Technologies of the Future

Link to Metadata

Care in Healthcare Reflections on Theory and Practice /

Link to Metadata

Precision Oncology and Cancer Biomarkers Issues at Stake and Matters of Concern /

Link to Metadata

Vessel Health and Preservation: The Right Approach for Vascular Access

Link to Metadata

The Ethics of Medical Data Donation

Link to Metadata

Water-filtered Infrared A (wIRA) Irradiation From Research to Clinical Settings /

Link to Metadata

Health Promotion in Health Care - Vital Theories and Research

Link to Metadata